Optimizing Care to Improve Outcomes for Patients with COPD
Release Date: June 30, 2014
Last Reviewed: June 11, 2014
Expiration Date: June 30, 2015
Time to Complete:  1.75 hours

*This activity expired for credit on June 30, 2015 and is no longer available for credit
This activity is sponsored by Global Education Group. 
Paradigm Medical Communications, LLC is the educational partner.
Brian W. Carlin, MD (Chair)
Assistant Professor of Medicine
Drexel University School of Medicine
Sleep Medicine and Lung Health Consultants
Pittsburgh, PA
Jennifer D. Possick, MD
Assistant Professor of Medicine
Section of Pulmonary, Critical Care, and Sleep Medicine
Associate Director
Winchester Chest Clinic
Yale University School of Medicine
New Haven, CT
Sanjay Sethi, MD
Professor and Chief
Pulmonary, Critical Care, and Sleep Medicine
Vice Chair for Research
University at Buffalo, The State University of New York
Buffalo, NY
Target Audience
This activity has been designed to address the educational needs of physicians, nurse practitioners, and physician assistants with an interest in the management of COPD who were unable to attend the live symposium, or who attended the live symposium and wish to reinforce their learning. The webinar is also intended for other HCPs interested in the management of patients with COPD.
Statement of Need
In recognition of the need to improve care for patients with COPD, in 2011 clinical practice guidelines for the Diagnosis and Management of Stable COPD were published by several leading associations. Since that time, the 2013 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report was published and several new medications have been approved. This enduring webinar will provide an update on these guidelines and therapies, as well as current evidence-based information about the CMS Core Measures, which need to be thoroughly understood, as the prevention of a hospital admission has a direct effect on minimizing hospital readmission.
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
  • Describe the impact of COPD and the proposed CMS Core Measures and Readmissions Reduction Program related to COPD.
  • Develop an evidence-based approach for performing appropriate assessment to confirm a diagnosis and determine severity of illness.
  • Explain current evidence-based guidelines for developing an individualized maintenance regimen for patients with COPD.
  • Outline strategies to ensure adherence, continuity of care, and self-management for patients with COPD throughout the healthcare system.
  • Welcome and Introductions
  • Impact of COPD and Opportunities to Improve Care
  • Making the Diagnosis and Determining the Severity of Illness
  • Evidence-Based Approaches to Improve COPD Care
  • Ensuring Adherence and Continuity of Care to Optimize Outcomes
  • Q&A
Physician Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physician Credit Designation Statement
Global Education Group designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistant Continuing Education
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.75 hours of Category 1 credit for completing this program.
Nurse Practitioner Continuing Education
Global Education Group is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 1101021.
This program has been approved for 1.75 contact hours of continuing education (which includes 0.75 hours of pharmacology).
This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standard.
Disclosure of Commercial Support
This activity is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc,
Forest Research Institute, a subsidiary of Forest Laboratories, Inc, and Sunovion Pharmaceuticals, Inc.
Instructions for Participation
To receive a CME certificate of participation, participants should:
  • Follow instructions to register or log in with your professional information and complete the pretest.
  • View the online activity in its entirety.
  • Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the activity.
A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.
There is no fee required for participation in this activity.
Hardware/Software Requirements
This certified CME activity is designed using HTML5 video. As you navigate the video using the supplied controls, the slides will sync to the speaker.
Supported Browsers:
For Desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
For your convenience, use the control bar buttons to move forward and backward through the presentation.
Technical Support: If you have any technical problems or playback issues, please click on the Technical Support button on the left of the screen or email us at contactus@paradigmmc.com.
In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
Name of Faculty or Presenter
Reported Financial Relationship
Brian W. Carlin, MD (Chair)
Grant/Research Support:Breathe Technologies; Respironics, Inc
Speakers Bureau:Boehringer Ingelheim Pharmaceuticals, Inc; Breathe Technologies; Forest Laboratories, Inc; GlaxoSmithKline; Respironics, Inc
Jennifer D. Possick, MD
No financial conflicts to disclose.
Sanjay Sethi, MD
Retained Consultant:Boehringer Ingelheim Pharmaceuticals, Inc; Forest Laboratories, Inc; GlaxoSmithKline; Novartis Pharmaceutical Corporation; Pfizer Inc
Grant/Research Support:AstraZeneca; Dey Pharma; MedImmune, LLC; Pearl Therapeutics Inc
Speakers Bureau:: Bayer HealthCare AG; Boehringer Ingelheim Pharmaceuticals, Inc; Forest Laboratories, Inc; Novartis Pharmaceutical Corporation
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Name of Planner or Manager
Reported Financial Relationship
Ashley Marostica, RN, MSN
Nothing to disclose
Amanda Glazar, PhD
Nothing to disclose
Amanda Hodges
Nothing to disclose

Paradigm Medical Communications, LLC staff members have no financial conflicts to disclose.

Independent peer reviewer has no financial conflicts to disclose.
Resolution of Conflict of Interest
Paradigm Medical Communications, LLC and Global Education Group have implemented a system to resolve conflicts of interest for each CME activity to help ensure content objectivity, independence, fair balance, and that the content is aligned with the interest of the public. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC or Global Education Group. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
Signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
Terms of Use and Privacy Policy
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC or Global Education Group. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm or Global. Paradigm and Global accept no liability for the content referenced in this activity.
Privacy policy
Paradigm and Global arecommitted to protecting the privacy of those who participate in the activities (herein referred to as "website") located at www.paradigmmc.com. The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm and Global to continuously improve the learning experience.
Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.
Contact Us
If you have any questions or comments, please email contactus@paradigmmc.com.
© 2014 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.